Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -1.63%14.64B | 31.23%14.88B | 67.62%18.5B | 22.51%53.47B | 43.54%16.22B | 51.18%14.88B | 8.67%11.34B | -8.59%11.04B | -18.12%43.65B | -15.84%11.3B |
| Operating revenue | -1.63%14.64B | 31.23%14.88B | 67.62%18.5B | 22.51%53.47B | 43.54%16.22B | 51.18%14.88B | 8.67%11.34B | -8.59%11.04B | -18.12%43.65B | -15.84%11.3B |
| Cost of revenue | -4.80%9.89B | 47.25%9.95B | 99.56%12.36B | 31.67%34.21B | 65.94%10.88B | 73.19%10.38B | 11.58%6.76B | -16.04%6.19B | -29.61%25.98B | -24.64%6.55B |
| Gross profit | 5.67%4.75B | 7.60%4.93B | 26.79%6.14B | 9.03%19.27B | 12.58%5.34B | 16.89%4.5B | 4.64%4.58B | 3.11%4.85B | 7.72%17.67B | 0.36%4.74B |
| Operating expense | 8.86%2.48B | 0.09%2.31B | 15.79%2.47B | 9.62%9.43B | 9.03%2.7B | 11.00%2.28B | 13.81%2.31B | 4.76%2.13B | 4.64%8.6B | 9.69%2.48B |
| Other operating expenses | 8.86%2.48B | 0.09%2.31B | 15.79%2.47B | 9.62%9.43B | 9.03%2.7B | 11.00%2.28B | 13.81%2.31B | 4.76%2.13B | 4.64%8.6B | 9.69%2.48B |
| Operating profit | 2.39%2.27B | 15.22%2.62B | 35.45%3.67B | 8.48%9.84B | 16.48%2.64B | 23.63%2.22B | -3.28%2.27B | 1.84%2.71B | 10.83%9.07B | -8.19%2.26B |
| Net non-operating interest income (expenses) | 3.96%-1.26B | -9.15%-1.18B | -47.40%-1.33B | -15.92%-4.42B | -1.36%-1.12B | -42.67%-1.31B | -22.54%-1.08B | 0.00%-905M | -19.91%-3.81B | -27.81%-1.1B |
| Non-operating interest expense | -3.96%1.26B | 9.15%1.18B | 47.40%1.33B | 14.10%4.4B | -4.18%1.1B | 42.67%1.31B | 22.54%1.08B | 0.00%905M | 19.63%3.86B | 26.43%1.15B |
| Total other finance cost | ---- | ---- | ---- | 140.00%18M | ---- | ---- | ---- | ---- | 0.00%-45M | ---- |
| Other net income (expenses) | -81.99%154M | 0.00%1.55B | 485.52%849M | -28.31%1.88B | -162.56%-670M | 800.82%855M | 47.10%1.55B | -76.58%145M | 666.09%2.62B | 149.77%1.07B |
| Gain on sale of security | -328.51%-505M | 593.21%1.09B | 82.74%-127M | -400.29%-2.08B | -255.50%-1.34B | 135.59%221M | -144.83%-221M | -1,611.63%-736M | 169.06%692M | 270.39%863M |
| Special income (charges) | --0 | -130.25%-330M | ---- | 315.04%901M | 54.65%-190M | --0 | --1.09B | ---- | 78.29%-419M | 86.06%-419M |
| -Less:Restructuring and mergern&acquisition | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Impairment of capital assets | --0 | --330M | ---- | -54.65%190M | --190M | --0 | --0 | ---- | -86.06%419M | ---- |
| -Gain on sale of business | --0 | --0 | ---- | --1.09B | --0 | --0 | --1.09B | ---- | --0 | --0 |
| Other non-operating income (expenses) | 34.19%208M | 46.84%279M | 33.51%247M | 41.35%752M | 48.99%222M | -0.64%155M | 131.71%190M | 27.59%185M | 28.81%532M | 46.08%149M |
| Income before tax | -33.88%1.16B | 9.01%2.99B | 63.35%3.19B | -7.36%7.3B | -61.96%849M | 134.22%1.76B | 8.73%2.74B | -17.89%1.95B | 73.47%7.88B | 506.56%2.23B |
| Income tax | 1.28%316M | -9.88%666M | 80.57%697M | -8.40%1.67B | -65.21%231M | 143.75%312M | 42.39%739M | -24.31%386M | 13.53%1.82B | 18.57%664M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -41.47%847M | 15.99%2.32B | 59.11%2.49B | -7.05%5.63B | -60.59%618M | 132.26%1.45B | 0.00%2B | -16.13%1.57B | 106.19%6.06B | 241.39%1.57B |
| Net income continuous operations | -41.47%847M | 15.99%2.32B | 59.11%2.49B | -7.05%5.63B | -60.59%618M | 132.26%1.45B | 0.00%2B | -16.13%1.57B | 106.19%6.06B | 241.39%1.57B |
| Noncontrolling interests | 5.36%59M | -27.59%42M | 137.74%126M | 242.86%190M | 109.20%23M | 2,700.00%56M | -12.12%58M | 8.16%53M | -104.62%-133M | -98.41%-250M |
| Net income attributable to the company | -43.35%788M | 17.29%2.28B | 56.35%2.36B | -12.11%5.44B | -67.27%595M | 123.99%1.39B | 0.41%1.94B | -16.79%1.51B | 106.16%6.19B | 284.94%1.82B |
| Preferred stock dividends | 8.16%106M | 7.37%102M | 10.75%103M | 10.23%388M | 10.87%102M | 10.11%98M | 9.20%95M | 10.71%93M | -14.98%352M | 9.52%92M |
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -47.25%682M | 17.80%2.18B | 59.34%2.26B | -13.46%5.05B | -71.44%493M | 143.05%1.29B | 0.00%1.85B | -18.12%1.42B | 125.53%5.84B | 261.76%1.73B |
| Diluted earnings per share | -49.15%0.3 | 16.28%1 | 55.22%1.04 | -17.61%2.34 | -73.17%0.22 | 126.92%0.59 | -5.49%0.86 | -22.09%0.67 | 121.88%2.84 | 257.69%0.82 |
| Basic earnings per share | -49.15%0.3 | 16.28%1 | 53.73%1.03 | -17.61%2.34 | -73.17%0.22 | 126.92%0.59 | -5.49%0.86 | -21.18%0.67 | 121.88%2.84 | 257.69%0.82 |
| Dividend per share | 3.01%0.9425 | 3.01%0.9425 | 3.01%0.9425 | 3.10%3.66 | 3.10%0.915 | 3.10%0.915 | 3.10%0.915 | 3.10%0.915 | 3.20%3.55 | 3.20%0.8875 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.